The synthesis of antimicrobial activity spirocompounds was achieved via the reaction of hydrazonoyl halides 1 with exocyclic 4-arylidene-2-methylimidazolin-5-one 3 in benzene in the presence of triethylamine. Correct elemental analyses and spectral data (IR, 1 H NMR, 13 C NMR and MS) confirm the structure of the synthesized spirocompounds. All the synthesized compounds were evaluated in vitro for their antimicrobial activity against five gram-positive and two gram-negative bacteria using well diffusion method in Mueller-Hinton agar. Most of them exhibited significant antibacterial activity compared with selected standard drugs.
Introduction
Spirocompounds form a group of generally less investigated compounds. However, recently growing efforts have been made to synthesize, characterize and investigate the biological activities of these compounds. Many spirocompounds possess very promising biological activities as anticancer agents (Young-Won et al., 2003; Wen-Liang et al., 2007) , antibacterial agents (van-der-Sar et al., 2006; Hyeong-Beom et al., 2007) , anticonvulsant agents Krzysztof et al., 2008; , anti tuberculosis agents (Chande et al., 2005) , anti-Alzheimer's agents (Masakazu et al., 2001) , pain-relief agents (Frank et al., 2003; Hans et al., 2006) , anti-dermatitis agents (Nakao et al., 2008) and antimicrobial agents (Pawar et al., 2009; Thadhaney et al., 2010) . In addition to their medical uses, some spirocompounds have found other uses in the agricultural and industrial fields. For example, they are used as antifungal agents (Hejiao et al., 2006) , pesticides (Lindell et al., 2001) , laser dyes (Kreuder et al., 1999) and electroluminescent devices (Lupo et al., 2008) . Spiro compounds have also been recently used as antioxidants (Sarma et al., 2010; Shimakawa et al., 2003) . Also, the pyrazoline derivatives are very interesting compounds due to their important role for the antifungal (Korgaokar et al., 1996; Abunada et al., 2009) , antidepressant (Palaska et al., 2003; Rajendra et al., 2005; Ozdemir et al., 2007; Ruhogluo et al., 2005) , anticonvulsant (Ozdemir et al., 2007; Ruhogluo et al., 2005) , anti-inflammatory (Karabasanagouda et al., 2009) , antibacterial (Abunada et al., 2009; Nauduri & Reddy, 1998) and anti-tumor (Taylor & Patel, 1992) activity. Besides, it is known that the imidazolinone derivatives are associated with a wide range of therapeutic activities such as anticonvulsant (Godefroi & Platje, 1972) , potent CNS depressant, (Harfenist et al., 1978) . Recently some new imidazolinone derivatives have been reported as antimicrobial (Desai et al., 2009; Solankee et al., 2004) , anticancer (Solankee et al., 2004) and L-DOPA prodrugs in the treatment of Parkinson's disease (Giorgionia et al., 2010) . In view of these results and as continuation of our reaction mixture was filtered while hot to remove triethylamine hydrochloride salt and evaporated under reduced pressure till dryness and the remaining residue was triturated with ethanol (10 ml). The separated solid compound was filtered off and crystallized from a given solvent. 3, 4, 2, 7, 4] O: C, 78.92; H, 5.30; N, 12.27. Found: C, 78.63; H, 5.25; N, 4, 2, 7, 4] 115.200, 121.521, 127.125, 127.873, 128.021, 128.285, 128.487, 128.781, 129.143, 129.196, 129.727 (11C, CHArC's), 129.902, 132.553, 132.576, 133.518, 143.376, 148.713, 161.255 125.889, 126.698, 127.228, J = 3.5 Hz, 128.212, J = 8.6 Hz, C-m-F), 129.74 (9C, ArCH's), 129.894, 130.154, 132.271, 139.126, 140.057, 148.018, 152.108, 162.781, 164.483-161.187 114.723, 120.823, 121.239, 126.701, 127.518, 27.720, 127.834, 128.334, 128.784, 128.914, 129.036, 129.185 (13C, CHArC's), 130.249, 131.096, 132.565, 143.296, 149.07, 154.629, 161.873 115.166, 115.372, 121.452, 124.886, 127.850, 127.983, 128.269, 128.399, 128.456, 128.492 (10C, CHArC's), 129.177, 129.925, 132.591, 133.526, 143.425, 148.632, 158.886, 161.744 , 67.28; H, 4.71; N, 13.08. Found: C, 67.30; H, 4.73; N, 2, 7, 4] 113.033, 114.525, 114.849, 120.735, 120.922, 124.161, 124.579, 126.499, 128.117, 128.670, 128.822, 128.933 (12C, CHArC's), 129.063, 131.054, 131.218, 143.185, 149.105, 154.965, 158.661, 160.897 (8C, C=N, ArC's) C, 74.40; H, 5.46; N, 10.85. Found: C, 74.42; H, 5.49; N, 11.00%. 3-(4-Chlorophenyl)-7-(2-methoxyphenyl)-4-(4-methoxyphenyl)-8-methyl-1-phenyl-1,2,7,9-tetrazaspiro[4,4]non a-2,8-dien-6-one 4v. Off white crystals, yield 82%; mp 134 -136 ℃ (benzene/ethanol); IR (KBr) ν max /cm -1 3066.6, 3039.6 (aromatic CH), 2966 .3, 2953 .5, 2839 
In Vitro Antimicrobial Activity Screening
For the in vitro antimicrobial activity, a stock solution of the synthesized compound (1000 μg/mL) in DMSO was prepared and 30 μl of graded dilutions (Table 1 ) of the tested compounds were incorporated in a cavity (depth 3 mm, diameter 4 mm) made in the center of the petri plate which corresponding to 30 μg, 15 μg, 7.5 μg and 3.75 μg. The plates were allowed to stand at room temperature for two hours for diffusion and then incubated. The organisms were grown on Muller Hinton's agar with sheep blood (5 %) at 37 ℃ for 24 hours. After incubation period, the clear zone around the wells was carefully measured in mm as inhibition zones. The absence of a clear zone around the well was taken as inactivity. The antibiotics Amoxycillin (10 μg/disc), Amikacin (10 μg/disc), Ceftriazone (10 μg/disc), and Ciprofloxacin (30 μg/disc) were used as references and dimethylsulphoxide (DMSO) as solvent and control. The investigation results are listed in Table 1 . 2a-f 1a-f 4a, Ph / Ph / Ph / Ph 4b, Ph / Ph / 4-ClC 6 H 4 / Ph 4c, Ph / Ph / 2,4-Cl 2 C 6 H 3 / 4-NO 2 C 6 H 4 4d, Ph / Ph / 2-f uryl / 4-NO 2 C 6 H 4 4e, Ph / 4-CH 3 C 6 H 4 / Ph / Ph 4f , Ph / 4-CH 3 C 6 H 4 / 4-ClC 6 H 4 / Ph 4g, Ph / 4-CH 3 C 6 H 4 / 4-FC 6 H 4 / 4-NO 2 C 6 H 4 4h, Ph / 4-CH 3 C 6 H 4 / Ph / 4-NO 2 C 6 H 4 4i, Ph / 4-CH 3 C 6 H 4 / 2-f uryl / 4-NO 2 C 6 H 4 4j, Ph / 2-CH 3 OC 6 H 4 / Ph / Ph 4k, Ph / 2-CH 3 OC 6 H 4 / 4-ClC 6 H 4 / Ph 3a, Ph / Ph 3b, Ph / 4-CH 3 C 6 H 4 3c, Ph / 2-CH 3 OC 6 H 4 3d, Ph / 3-CH 3 OC 6 H 4 3e, Ph / 4-C 2 H 5 OC 6 H 4 3f , 4-CH 3 OC 6 H 4 / 2-CH 3 OC 6 H 4 1a, 2a, Ph / Ph / Cl 1b, 2b, 4-ClC 6 H 4 / Ph / Cl 1c, 2c, 2,4-Cl 2 C 6 H 3 / 4-NO 2 C 6 H 4 / Br 1d, 2d, 4-FC 6 H 4 / 4-NO 2 C 6 H 4 / Br 1e, 2e, Ph / 4-NO 2 C 6 H 4 / Br 1f , 2f, 2-f uryl / 4-NO 2 C 6 H 4 / Cl 4l, Ph / 2-CH 3 OC 6 H 4 / 2,4-Cl 2 C 6 H 3 / 4-NO 2 C 6 H 4 4m, Ph / 2-CH 3 OC 6 H 4 / 2-furyl / 4-NO 2 C 6 H 4 4n, Ph / 3-CH 3 OC 6 H 4 / Ph / Ph 4o, Ph / 3-CH 3 OC 6 H 4 / 4-ClC 6 H 4 / Ph 4p, Ph / 3-CH 3 OC 6 H 4 / 4-FC 6 H 4 / 4-NO 2 C 6 H 4 4q, Ph / 4-C 2 H 5 OC 6 H 4 / Ph / Ph 4r, Ph / 4-C 2 H 5 OC 6 H 4 / 4-ClC 6 H 4 / Ph 4s, Ph / 4-C 2 H 5 OC 6 H 4 / 2,4-Cl 2 C 6 H 3 / 4-NO 2 C 6 H 4 4t, Ph / 4-C 2 H 5 OC 6 H 4 / 2-furyl / 4-NO 2 C 6 H 4 4u, 4-CH 3 OC 6 H 4 / 2-CH 3 OC 6 H 4 / Ph / Ph 4v, 4-CH 3 OC 6 H 4 / 2-CH 3 OC 6 H 4 / 4-ClC 6 H 4 / Ph 
